Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.

Griesinger AM, Widener M, Donson AM, Mettetal A, Hankinson TC, Handler M, Mulcahy Levy JM, Lindsay HB, Macy ME, Foreman NK, Dorris K

Open source

DOI: 10.1093/neuonc/noag066
Published: 2026 Jul 1
Container: Neuro-oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noag066,
  title = {Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.},
  author = {Griesinger AM and Widener M and Donson AM and Mettetal A and Hankinson TC and Handler M and Mulcahy Levy JM and Lindsay HB and Macy ME and Foreman NK and Dorris K},
  year = {2026},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noag066},
  url = {https://doi.org/10.1093/neuonc/noag066}
}

RIS

TY  - JOUR
TI  - Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.
AU  - Griesinger AM
AU  - Widener M
AU  - Donson AM
AU  - Mettetal A
AU  - Hankinson TC
AU  - Handler M
AU  - Mulcahy Levy JM
AU  - Lindsay HB
AU  - Macy ME
AU  - Foreman NK
AU  - Dorris K
PY  - 2026
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noag066
UR  - https://doi.org/10.1093/neuonc/noag066
ER  -

APA

AM, G., M, W., AM, D., A, M., TC, H., M, H., JM, M. L., HB, L., ME, M., NK, F., & K, D. (2026). Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.. Neuro-oncology. https://doi.org/10.1093/neuonc/noag066

Source records

pubmed · retrieved 2026-09-25T13:54:30.501Z